What is the recommended evaluation and management of fever in a patient with known Moyamoya disease?

Fever in Moyamoya Disease: Evaluation and Management

In a patient with known Moyamoya disease presenting with fever, you must urgently evaluate for both infectious causes (as in any critically ill patient) AND consider stroke (ischemic or hemorrhagic) as a critical non-infectious etiology, since fever can be an atypical presenting symptom of acute cerebrovascular events in Moyamoya patients.

Initial Approach: Dual Diagnostic Pathway

The evaluation requires simultaneous consideration of two distinct pathways:

1. Stroke Evaluation (Priority in Moyamoya)

Fever with neurological symptoms (even subtle ones like confusion, speech changes, or transient weakness) should trigger immediate stroke workup 1, 2:

• Obtain urgent brain MRI - This is critical as Moyamoya patients can present with fever and confusion as the primary manifestation of acute infarction 1
• Look specifically for:
  • New infarcts (particularly basal ganglia, frontal, or parietal regions)
  • Hemorrhagic transformation
  • Signs of acute thrombotic occlusion at stenotic sites 3
• Perform detailed neurological examination focusing on:
  • Focal weakness (even if transient)
  • Speech disturbances
  • Altered mental status beyond what fever alone would explain
  • New headache patterns

Critical pitfall: Moyamoya disease can mimic encephalitis, presenting with fever, decreased consciousness, and seizures 2. Don't assume infection without neuroimaging.

2. Infectious Evaluation (Standard ICU Approach)

Following the 2023 SCCM/IDSA guidelines 4, evaluate for infectious causes but recognize that not all fevers require exhaustive workup:

• Target your diagnostic studies based on history and physical findings rather than reflexively ordering all cultures
• Consider the extensive differential of non-infectious fever causes, particularly relevant to Moyamoya:
  • Intracranial hemorrhage (listed as non-infectious fever cause) 4
  • Stroke (listed as non-infectious fever cause) 4
  • Drug fever
  • Venous thrombosis

Management Considerations Specific to Moyamoya

Avoid Medications That Compromise Cerebral Perfusion

When treating fever or associated symptoms in Moyamoya patients:

• Avoid vasoconstrictors (triptans, ergots) 5
• Avoid medications that limit vasodilation (CGRP-targeted therapies) 5
• Avoid blood pressure lowering agents (β-blockers, calcium channel blockers) that could compromise already tenuous cerebral perfusion 5

Antiplatelet Therapy Considerations

• If ischemic event is confirmed, antiplatelet therapy is reasonable for secondary prevention 5
• Cilostazol (a vasodilator antiplatelet) may offer advantages over other antiplatelet agents for cerebral blood flow 5

Key Clinical Pearls

High-risk presentations that should raise immediate concern for stroke rather than simple infection:

• Fever with ANY focal neurological symptoms, even if transient 1, 6
• Fever with confusion or altered mental status disproportionate to fever severity 1, 2
• Sudden-onset symptoms without preceding TIAs, even in early angiographic stages 3

Diagnostic sequence:

1. Urgent neurological examination
2. Brain MRI (not just CT - MRI is superior for detecting early ischemia) 2
3. If MRI shows vascular lesion, proceed to MRA or vessel wall imaging 2, 3
4. Simultaneously pursue infectious workup if no clear stroke etiology found

The evidence strongly suggests that in Moyamoya patients, fever should never be dismissed as purely infectious without neuroimaging, as multiple case reports demonstrate stroke presenting primarily with fever and minimal focal findings 1, 2.